Implications of Toll-like receptors in Ebola infection

Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe

(2016) Selidji T. Agnandji et al.   NEW ENGLAND JOURNAL OF MEDICINE

Toll-like receptors as targets for allergen immunotherapy

(2015) Zahra Aryan et al.   Current Opinion in Allergy and Clinical Immunology

Toll-like receptors: Activation, signalling and transcriptional modulation

(2015) Dominic De Nardo   CYTOKINE

Inflammation in venous thromboembolism: Cause or consequence?

(2015) Amene Saghazadeh et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Suppressor of Cytokine Signaling 3 Is an Inducible Host Factor That Regulates Virus Egress during Ebola Virus Infection

(2015) Atsushi Okumura et al.   JOURNAL OF VIROLOGY

Ebola Virus VP24 Targets a Unique NLS Binding Site on Karyopherin Alpha 5 to Selectively Compete with Nuclear Import of Phosphorylated STAT1

(2014) Wei Xu et al.   Cell Host & Microbe

Novel drugs targeting Toll-like receptors for antiviral therapy

(2014) Mira C Patel et al.   Future Virology

Toll-like Receptor and Inflammasome Signals Converge to Amplify the Innate Bactericidal Capacity of T Helper 1 Cells

(2014) Hope O’Donnell et al.   IMMUNITY

A New Era of Targeting the Ancient Gatekeepers of the Immune System: Toll-Like Agonists in the Treatment of Allergic Rhinitis and Asthma

(2014) Zahra Aryan et al.   INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY

Clinical features and pathobiology of Ebolavirus infection

(2014) Aftab A. Ansari   JOURNAL OF AUTOIMMUNITY

Molecular Basis for Ebolavirus VP35 Suppression of Human Dendritic Cell Maturation

(2014) B. Yen et al.   JOURNAL OF VIROLOGY

Ebola — Underscoring the Global Disparities in Health Care Resources

(2014) Anthony S. Fauci   NEW ENGLAND JOURNAL OF MEDICINE

Toll-Like Receptor Agonist Augments Virus-Like Particle-Mediated Protection from Ebola Virus with Transient Immune Activation

(2014) Karen A. O. Martins et al.   PLoS One

Shed GP of Ebola Virus Triggers Immune Activation and Increased Vascular Permeability

(2014) Beatriz Escudero-Pérez et al.   PLoS Pathogens

The International Code of Virus Classification and Nomenclature (ICVCN): proposal for text changes for improved differentiation of viral taxa and viruses

(2013) Jens H. Kuhn et al.   ARCHIVES OF VIROLOGY

Virus nomenclature below the species level: a standardized nomenclature for laboratory animal-adapted strains and variants of viruses assigned to the family Filoviridae

(2013) Jens H. Kuhn et al.   ARCHIVES OF VIROLOGY

Toll-like receptor signalling and their therapeutic targeting in colorectal cancer

(2013) Shirin Moossavi et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Critical Role of AZI2 in GM-CSF-Induced Dendritic Cell Differentiation

(2013) M. Fukasaka et al.   JOURNAL OF IMMUNOLOGY

Toll like receptor (TLR)-induced differential expression of microRNAs (MiRs) and immune response against infection: A systematic review

(2013) Seyed Hossein Aalaei-andabili et al.   JOURNAL OF INFECTION

Ebola Virus-Like Particles Stimulate Type I Interferons and Proinflammatory Cytokine Expression Through the Toll-Like Receptor and Interferon Signaling Pathways

(2013) Natarajan Ayithan et al.   JOURNAL OF INTERFERON AND CYTOKINE RESEARCH

mAbs and Ad-Vectored IFN-  Therapy Rescue Ebola-Infected Nonhuman Primates When Administered After the Detection of Viremia and Symptoms

(2013) X. Qiu et al.   Science Translational Medicine

Trial Watch

(2013) Erika Vacchelli et al.   OncoImmunology

Toll-like Receptor Signaling Pathways in Cardiovascular Diseases: Challenges and Opportunities

(2012) Faezeh Moghimpour Bijani et al.   INTERNATIONAL REVIEWS OF IMMUNOLOGY

Interferon-β Therapy Prolongs Survival in Rhesus Macaque Models of Ebola and Marburg Hemorrhagic Fever

(2012) Lauren M. Smith et al.   JOURNAL OF INFECTIOUS DISEASES

The ebolavirus VP24 interferon antagonist

(2012) Adrianna P.P. Zhang et al.   Virulence

Antigenic Subversion: A Novel Mechanism of Host Immune Evasion by Ebola Virus

(2012) Gopi S. Mohan et al.   PLoS Pathogens

The Ebola Virus Interferon Antagonist VP24 Directly Binds STAT1 and Has a Novel, Pyramidal Fold

(2012) Adrianna P. P. Zhang et al.   PLoS Pathogens

Ebolavirus VP35 suppresses IFN production from conventional but not plasmacytoid dendritic cells

(2011) Lawrence W Leung et al.   IMMUNOLOGY AND CELL BIOLOGY

Alum adjuvant: some of the tricks of the oldest adjuvant

(2011) M. Kool et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Targeting of Toll-like receptors: a decade of progress in combating infectious diseases

(2011) Mona Hedayat et al.   LANCET INFECTIOUS DISEASES

Programming the magnitude and persistence of antibody responses with innate immunity

(2011) Sudhir Pai Kasturi et al.   NATURE

A nonreplicating subunit vaccine protects mice against lethal Ebola virus challenge

(2011) W. Phoolcharoen et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Pattern Recognition Receptors and Inflammation

(2010) Osamu Takeuchi et al.   CELL

Type I interferon: friend or foe?

(2010) Giorgio Trinchieri   JOURNAL OF EXPERIMENTAL MEDICINE

Ebola haemorrhagic fever

(2010) Heinz Feldmann et al.   LANCET

Targeting Toll-like receptors: emerging therapeutics?

(2010) Elizabeth J. Hennessy et al.   NATURE REVIEWS DRUG DISCOVERY

Toll-like Receptor and RIG-1-like Receptor Signaling

(2009) Taro Kawai et al.   Annals of the New York Academy of Sciences

Ebolavirusglycoprotein structure and mechanism of entry

(2009) Jeffrey E Lee et al.   Future Virology

The VP35 protein of Ebola virus impairs dendritic cell maturation induced by virus and lipopolysaccharide

(2009) H. Jin et al.   JOURNAL OF GENERAL VIROLOGY

Ebola Virus Protein VP35 Impairs the Function of Interferon Regulatory Factor-Activating Kinases IKK  and TBK-1

(2009) K. C. Prins et al.   JOURNAL OF VIROLOGY

Interaction between Ebola Virus Glycoprotein and Host Toll-Like Receptor 4 Leads to Induction of Proinflammatory Cytokines and SOCS1

(2009) A. Okumura et al.   JOURNAL OF VIROLOGY

Therapeutic Targeting of Toll-Like Receptors for Infectious and Inflammatory Diseases and Cancer

(2009) L. A. J. O'Neill et al.   PHARMACOLOGICAL REVIEWS

Ebola Zaire Virus Blocks Type I Interferon Production by Exploiting the Host SUMO Modification Machinery

(2009) Tsung-Hsien Chang et al.   PLoS Pathogens

MDA5/RIG-I and virus recognition

(2008) Osamu Takeuchi et al.   CURRENT OPINION IN IMMUNOLOGY

LPS/TLR4 signal transduction pathway

(2008) Yong-Chen Lu et al.   CYTOKINE